Abstract:Abstract Background Polypharmacy increases the risk of potentially inappropriate medications (PIM) and drug-drug interactions (DDI). This study conducts a retrospective analysis to detect PIMs, DDIs and adverse drug reactions (ADR) among older adults with psychiatric disorders. Methods A retrospective analysis was carried out based on medical records of aged inpatient people with psychiatric disorders. Demographic details, hobbies, medical history, medication and laboratory examination were extracted. Three criteria and one online DDIs database were used to detect PIMs and DDIs. The minimally clinical important difference (MCID) was defined as the score change of the Treatment Emergent Symptom Scale (TESS) between admission and discharged. Mean and standard deviation (SD) was used for continuous variables and frequency was calculated for dichotomous variables. Ordinal regression was carried out to detect the independent factors of PIM. Binary logistic regression analysis was implemented to determine the independent factors on the likelihood of ADR or the MCID. ANOVA was used to detect the relationship between the co-administration of drugs and the changes of ALT, AST, urea nitrogen, creatinine, total cholesterol, triglycerides. P<0.05 was considered as statistically significant. Results 96.8% inpatients had at least 1 PIM and lorazepam was the most frequently prescribed drug (75.0%). Co-administration of three or more central nervous system (CNS) active drugs was the principal DDI (70.45%) and the most frequent DDI which should be avoided was the co-administration of lorazepam and olanzapine (55.5%). The common ADR were constipation (25.6%), hepatotoxicity (14.0%) and extrapyramidal symptoms (13.0%). The co-administration of quetiapine and potassium chloride was an independent risk factor of constipation (P=0.011, OR=10.821, 95%CI [1.738 67.748]) and the score change of TESS scale (P=0.024, OR=0.024, 95%CI [1.274 32.288]). Conclusions The rate of PIM in the elderly with psychiatric disorders is high and brought serious adverse consequences. Further studies to prevent medication-related problems and costs such as raising awareness of PIM and DDI among healthcare professionals and patients, regulating deprescription, the pharmacokinetic and pharmacodynamic mechanism of drugs induced DDIs, and the influence of different drug administration routes on DDIs among aged people are needed.

Prevalence of potentially inappropriate medications according to STOPP-Frail criteria in nursing home residents, the SHELTER study

Factors Associated with Potentially Inappropriate Prescriptions and Barriers to Medicines Optimisation among Older Adults in Primary Care Settings: a Systematic Review

Prevalence of Potentially Inappropriate Medications in Older Adults with Cognitive Impairment or Dementia Attending Memory Clinics: A Systematic Review and Meta-Analysis

Prevalence of potentially inappropriate prescribing among older adults: A comparison of the Beers 2012 and Screening Tool of Older Person's Prescriptions criteria version 2

Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: A systematic review

Use of the Screening Tool of Older Person's Prescriptions (STOPP) in older people admitted to an Australian hospital

Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population

Potentially Inappropriate Medication: A Pilot Study in Institutionalized Older Adults

2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors

Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

Use of potentially inappropriate psychotropic medicines among older adults in 23 residential aged care facilities in Australia: a retrospective cohort study

Potentially Inappropriate Medication Use in Primary Care in Switzerland

Prevalence of strong anticholinergic use in residents with and without cognitive impairment and frailty: Analysis from 106 nursing homes in 12 Asia-Pacific and European countries

Comparison of the Prevalence and Nature of Potentially Inappropriate Medication Use in Geriatric Outpatients Between Tertiary and Community Healthcare Settings: a Multicenter Cross-Sectional Study.

Deprescribing in older patients with advanced cancer referred to palliative care

Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia

Are Lists of Potentially Inappropriate Medications Associated with Hospital Readmissions? A Systematic Review

Potentially inappropriate medications with older people in intensive care and associated factors: a historic cohort study

Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer

Evaluation of Potentially Inappropriate Medication among Elderly Inpatients in Internal Medicine Depart-ment of Our Hospital by Beers Criteria and STOPP/START Criteria

Analysis of potentially inappropriate medication based on drug-drug interactions in older adults with psychiatric disorders: a retrospective study